Author

Chantelle E Bowers

University College LondonORCID 0009-0006-7765-5891Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Bioengineering· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell-cell communication· 1 Assay:flow cytometry· 1 Organism:human· 1 Approach:microscopy & imaging analysis· 1

Frequent Co-Authors

Courtney HimsworthiD· 2 shared Henrike P. MulleriD· 2 shared John AndersoniD· 2 shared Louis ChesleriD· 2 shared Sophie Munnings-Tomes· 2 shared Ailsa Greppi· 1 shared Alice VitaliiD· 1 shared Amy K Erbe-Gurel· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 41 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

Courtney HimsworthORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

ImmunologyPLoS ONEPeer-reviewedOct 27, 2026

CD47 blockade augments anti-GD2 driven phagocytosis in vitro but fails to improve in vivo efficacy in immune competent, chemoresistant neuroblastoma preclinical models

Courtney Himsworth, Thomas John Jackson, Chantelle E Bowers…·John Anderson

This study shows CD47 blockade enhances anti-GD2 phagocytosis in vitro but does not improve in vivo efficacy in neuroblastoma models.

DOI 10.1371/journal.pone.0353900

mouseproteomics

𝕏 PostBluesky

BioengineeringNature CommunicationsPeer-reviewedAug 5, 2025

Functional avidity of anti-B7H3 CAR-T constructs predicts antigen density thresholds for triggering effector function

Marta Barisa, Henrike P. Muller, Elisa Zappa…·John Anderson

The paper evaluates how the functional avidity of anti-B7H3 CAR-T constructs relates to their ability to trigger effector function against tumors with varying antigen density.

29 citationstop 1%

humanflow cytometry

𝕏 PostBluesky